Voglit-0.3MG Tab

Composition

Voglibose (0.3mg)

Uses of Voglit-0.3MG Tab

Management of type 2 diabetes mellitus to control post-meal (postprandial) blood sugar; used along with diet and exercise, alone or with other antidiabetic medicines.

• •Reduces post-meal blood sugar spikes
• •Improves overall glycaemic control in type 2 diabetes
• •Helps complement diet and exercise
• •Useful add-on with other antidiabetic medicines

How it works

Voglibose is an alpha-glucosidase inhibitor. It delays the breakdown and absorption of complex carbohydrates in the intestine, thereby reducing the rise in blood glucose after meals and improving overall glycaemic control.

Directions for use

Oral tablet. Usually taken just before meals or with the first bite of food as advised by the doctor. Follow prescribed dose and diet plan; do not skip meals. If hypoglycaemia occurs with combination therapy, treat with glucose (dextrose) rather than sucrose/table sugar.

Side effects

Common side effects of Voglit-0.3MG Tab may include:

• •Flatulence
• •abdominal pain
• •diarrhoea
• •bloating
• •nausea

Warnings & precautions

Use with caution in kidney or liver impairment; monitor liver enzymes if advised. Not recommended in diabetic ketoacidosis, inflammatory bowel disease/intestinal obstruction/colonic ulceration or chronic intestinal diseases with digestion/absorption disorders. Risk of hypoglycaemia increases when used with insulin or sulfonylureas; educate on symptoms and management. If severe abdominal symptoms or persistent diarrhoea occur, seek medical advice.